Core Viewpoint - Jinhai Medical Technology (02225) experienced a significant stock increase of over 6%, closing at 1.2 HKD with a trading volume of 29.22 million HKD, driven by the announcement of a new innovative technology in spinal surgery during the China International Import Expo [1] Company Summary - Jinhai Medical is set to jointly launch a new navigation-based endoscopic technology for spinal surgery in collaboration with Medtronic China during the eighth China International Import Expo [1] - This innovative technology aims to enhance precision and intelligence in spinal surgeries, potentially shortening the learning curve for clinicians in endoscopic techniques [1] - The expected outcome is a more efficient and widespread clinical application of spinal surgery techniques, marking a significant advancement in the field [1] Industry Summary - The announcement aligns with ongoing trends in the medical technology industry towards increased precision and efficiency in surgical procedures [1] - The collaboration with a major player like Medtronic China highlights the importance of partnerships in driving innovation within the healthcare sector [1]
今海医疗科技尾盘涨超6% 第八届进博会今日开幕 公司将发布导航下脊柱内镜创新技术